Cancel
John Stubenrauch
Chief Operating Officer
@
Nutcracker Therapeutics
ppd1.85w3plg041w@7iq55vfv449.lw0
Sign up to see email
See Linkedin
Known information
- Was Vice President Biologics Commercial Operations at Gilead Sciences following the acquisition of Immunomedics where he was Sr. Vice President of Manufacturing
- Led the development and commercialization of immuno-oncology, Antibody Drug Conjugate (ADC) product
- Has 25 years of experience in the BioPharma industry in leadership positions
- Was a site General Manager at AstraZeneca
- Held various positions at Merck Manufacturing Division in support of new product launches and supply
- Awarded a PhD in Chemical Engineering from The University of Pennsylvania
- Holds a MBA from The Wharton School of Business
About Nutcracker Therapeutics
Nutcracker Therapeutics is a biotechnology company focused on developing RNA-based treatments using a proprietary platform that combines advanced engineering with high-precision biosynthesis and microfluidic technology.
Report inaccurate information
